Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
01:01am, Monday, 02'nd Feb 2026
Pfizer Inc. (NYSE: PFE) will release earnings results for its fourth quarter, before the opening bell on Tuesday, Feb. 3.
Wall Street Week Ahead
07:03am, Sunday, 01'st Feb 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Here's Why Pfizer Stock Is Still a Buy
06:00am, Sunday, 01'st Feb 2026
Pfizer is one of the world's largest pharmaceutical companies. It has a long history of navigating the competitive and technically complex industry.
Passive Income Investors Will Love These Cheap Dividend Stocks
08:28pm, Saturday, 31'st Jan 2026
Passive income can help secure your retirement, but building a dependable income is not easy.
5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill
03:47am, Saturday, 31'st Jan 2026
Verizon, Altria, Pfizer, KeyCorp, and Regions Financial offer 'safer' dividends with yields from $1K invested exceeding share price. Long-term bond yields continue to rise. But investors looking for i
Pfizer: Buyer Beware, The Risk Outweighs The Reward
10:31am, Friday, 30'th Jan 2026
Pfizer: Buyer Beware, The Risk Outweighs The Reward
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
10:01am, Friday, 30'th Jan 2026
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings?
09:01am, Friday, 30'th Jan 2026
Pfizer PFE is set to report its fourth-quarter and full-year 2025 earnings on Feb. 3, before market open. The Zacks Consensus Estimate for sales and earnings for the fourth quarter is pegged at $16.9
Why Dividend Stocks Are Essential For What Comes Next
07:30am, Friday, 30'th Jan 2026
Why Dividend Stocks Are Essential For What Comes Next
3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year
07:00am, Friday, 30'th Jan 2026
All three have encountered headwinds in recent years. But they have also made progress toward addressing them.
Ahead of Pfizer (PFE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:16am, Thursday, 29'th Jan 2026
Get a deeper insight into the potential performance of Pfizer (PFE) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
Pfizer: A High-Yield Pharma At A Turning Point
09:00am, Thursday, 29'th Jan 2026
Pfizer remains in the 'green zone' in 2026 despite retail investors' pessimism over the approaching LOE cycle. I believe retail investors' fears about the end of exclusivity for Pfizer's blockbusters,
3 High-Yield Stocks to Buy Hand Over Fist in January
07:03am, Thursday, 29'th Jan 2026
Realty Income is a boring, high-yield stock built from the ground up to be reliable. Procter & Gamble's yield isn't huge, but its dividend streak is hugely impressive.
AustralianSuper Pty Ltd Boosts Stock Position in Pfizer Inc. $PFE
04:34am, Thursday, 29'th Jan 2026
AustralianSuper Pty Ltd boosted its position in shares of Pfizer Inc. (NYSE: PFE) by 72.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
This Could Be 1 of the Best Pharmaceutical Stock-Buying Opportunities I've Seen in Years
07:03pm, Wednesday, 28'th Jan 2026
The coronavirus contagion created a brilliant but relatively short-lived opportunity. R&D work that had been put on hold earlier during the COVID-19 pandemic is being caught up on now.
